CLINICAL_TRIALS
ClinicalTrials.gov record update
A Rollover Protocol For Patients Who Received Tremelimumab (CP-675,206 ) In Other Protocols
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00378482
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:15.736550+00:00
- Published At
- 2021-05-28T00:00:00+00:00
- Record Updated At
- 2024-08-22
- Results Posted At
- 2021-05-28
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Colorectal Neoplasms", "Melanoma", "Prostatic Neoplasms", "Renal Cell Carcinoma", "Neoplasms", "Patients Who Have/Have Had Melanoma and Other Tumors"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-08-22"- protocolSection.identificationModule.nctId
"NCT00378482"- protocolSection.identificationModule.officialTitle
"A Rollover Protocol For Patients Who Received Tremelimumab (CP-675,206 ) In Other Protocols"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-05-28"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.